Rensselaer Polytechnic Institute Biomedical Engineering Student Starts VitalIV to Tap into $80 Billion Infectious Disease Market

Published: May 04, 2012

The Business Review by Richard A. D'Errico, Web Editor

Colleen Costello’s biotech startup VitalIV is focused on eliminating common bacterial contamination in intravenous lines.

Her company is targeting an $80.2 billion market in the U.S. with products designed to reduce the incidents of patient infection and death in hospitals.

Costello, a 21-year-old senior biomedical engineering student at Rensselaer Polytechnic Institute, said the business idea was developed from a conversation with nurses at Albany Medical Center and Samaritan Hospital.

“I originally got very intrigued, passionate and interested in the medical/life sciences field when my brother was diagnosed at the age of 6 with Type 1 diabetes.

Back to news